Cypress Pharmaceutical Overview

  • Founded
  • 1993
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 170
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Cypress Pharmaceutical General Information

Description

Developer and provider of prescription products to pharmaceutical wholesalers, chain drug stores, and retail merchandisers in the United States. The company offers more than 150 products available for a broad group of therapeutic categories, including analgesics, cough/cold, fluorides/dental health, gastrointestinal, nutritional supplements, pediatrics, urinary tract products and women's health.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 135 Industrial Boulevard
  • Madison, MS 39110
  • United States
+1 (601) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cypress Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cypress Pharmaceutical‘s full profile, request access.

Request a free trial

Cypress Pharmaceutical Patents

Cypress Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2756942-C Phosphate-binding magnesium salts and uses thereof Active 10-Apr-2009 000000000
AU-2016213704-A1 Phosphate-binding magnesium salts and uses thereof Granted 10-Apr-2009 000000000
AU-2016213704-B2 Phosphate-binding magnesium salts and uses thereof Ceased 10-Apr-2009 000000000
CA-2756942-A1 Phosphate-binding magnesium salts and uses thereof Granted 10-Apr-2009 000000000
AU-2009344184-B2 Phosphate-binding magnesium salts and uses thereof Ceased 10-Apr-2009 A61K33/06

Cypress Pharmaceutical Executive Team (5)

Name Title Board Seat Contact Info
Max Draughn Founder, President & Chief Executive Officer
Jason Sanderson Chief Financial Officer & Secretary
Jerry Russ Director, Technology
Glenn Pruitt Executive Vice President
Greg Stofko Vice President, National Accounts
To view Cypress Pharmaceutical’s complete executive team members history, request access »

Cypress Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cypress Pharmaceutical Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cypress Pharmaceutical‘s full profile, request access.

Request a free trial